---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-220638"
form_type: "8-K"
ticker: "TYRA"
cik: "0001863127"
company_name: "Tyra Biosciences, Inc."
filed_at: "2026-05-13T12:00:44+00:00"
generated_at: "2026-05-13T12:08:55.935987+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Tyra Biosciences Q1 net loss $39.3M; cash $383.5M; SURF302 data August 2026

## Summary
- Net loss $39.3M vs $28.1M YoY; R&D expenses $33.5M (+34%) driven by dabogratinib trials.
- Cash, equivalents & marketable securities $383.5M; runway into 2H 2028.
- First patient dosed in LG-UTUC trial SURF303 (pivotal); initial results expected 2027.
- Initial SURF302 data (IR NMIBC) due August 2026; BEACH301 safety sentinel data Q4 2026.
- Appointed Habib Dable to Board; raised $147.9M net via ATM in Q1 2026.

## SEC filing metadata
- accession: 0001193125-26-220638
- form_type: 8-K
- ticker: TYRA
- cik: 0001863127
- company_name: Tyra Biosciences, Inc.
- filed_at: 2026-05-13T12:00:44+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1863127/000119312526220638/0001193125-26-220638-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1863127/000119312526220638/tyra-20260513.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-220638
- JSON: https://secwatch.observer/filing/0001193125-26-220638.json
- Plain text: https://secwatch.observer/filing/0001193125-26-220638.txt

## Key facts
- Earnings Releases
  Tyra Biosciences, Inc. reported financial results for first quarter ended March 31, 2026.
  - Period: first quarter ended March 31, 2026
  - Result: reported results
  source text: On May 13, 2026, Tyra Biosciences, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1863127/000119312526220638/0001193125-26-220638-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.